Literature DB >> 28330373

Readout-segmented echo-planar diffusion-weighted imaging in the assessment of orbital tumors: comparison with conventional single-shot echo-planar imaging in image quality and diagnostic performance.

Xiaoquan Xu1, Yanjun Wang1, Hao Hu1, Guoyi Su1, Hu Liu2, Haibin Shi1, Feiyun Wu1.   

Abstract

Background Readout-segmented echo-planar imaging (RS-EPI) could improve the imaging quality of diffusion-weighted imaging (DWI) in various organs. However, whether it could improve the imaging quality and diagnostic performance for the patients with orbital tumors is still unknown. Purpose To compare the image quality and diagnostic performance of RS-EPI DWI with that of conventional single-shot EPI (SS-EPI) DWI in patients with orbital tumors. Material and Methods SS-EPI and RS-EPI DW images of 32 patients with pathologically diagnosed orbital tumors were retrospectively analyzed. Qualitative imaging parameters (imaging sharpness, geometric distortion, ghosting artifacts, and overall imaging quality) and quantitative imaging parameters (apparent diffusion coefficient [ADC], signal-to-noise ratio [SNR], contrast, and contrast-to-noise ratio [CNR]) were assessed by two independent radiologists, and compared between SS-EPI and RS-EPI DWI. Receiver operating characteristic curves were used to determine the diagnostic value of ADC in differentiating malignant from benign orbital tumors. Results RS-EPI DW imaging produced less geometric distortion and ghosting artifacts, and better imaging sharpness and overall imaging quality than SS-EPI DWI (for all, P < 0.001). Meanwhile, RS-EPI DWI produced significantly lower SNR ( P < 0.001) and ADC ( P < 0.001), and higher contrast ( P < 0.001) than SS-EPI DWI, while producing no difference in CNR ( P = 0.137). There was no significant difference on the diagnostic performance between SS-EPI and RS-EPI DWI, when using ADC as the differentiating index ( P = 0.529). Conclusion Compared with SS-EPI, RS-EPI DWI provided significantly better imaging quality and comparable diagnostic performance in differentiating malignant from benign orbital tumors.

Entities:  

Keywords:  Orbit; diffusion-weighted imaging; magnetic resonance imaging (MRI); readout-segmented echo-planar imaging; single-shot echo-planar imaging

Mesh:

Year:  2017        PMID: 28330373     DOI: 10.1177/0284185117695667

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.

Authors:  Nan Huang; Zebin Xiao; Yu Chen; Dejun She; Wei Guo; Xiefeng Yang; Qi Chen; Dairong Cao; Tanhui Chen
Journal:  Neuroradiology       Date:  2021-07-09       Impact factor: 2.804

2.  Applicability of readout-segmented echoplanar diffusion weighted imaging for prostate MRI.

Authors:  Susanne Hellms; Marcel Gutberlet; Matti Joonas Peperhove; Stefanie Pertschy; Christoph Henkenberens; Inga Peters; Frank Wacker; Katja Derlin
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Performance of TGSE BLADE DWI compared with RESOLVE DWI in the diagnosis of cholesteatoma.

Authors:  Yaru Sheng; Rujian Hong; Yan Sha; Zhongshuai Zhang; Kun Zhou; Caixia Fu
Journal:  BMC Med Imaging       Date:  2020-04-19       Impact factor: 1.930

4.  Turbo Gradient and Spin Echo PROPELLER-Diffusion Weighted Imaging for Orbital Tumors: A Comparative Study With Readout-Segmented Echo-Planar Imaging.

Authors:  Qing Fu; Xiang-Chuang Kong; Ding-Xi Liu; Kun Zhou; Yi-Hao Guo; Zi-Qiao Lei; Chuan-Sheng Zheng; Fan Yang
Journal:  Front Neurosci       Date:  2021-11-30       Impact factor: 4.677

5.  Time Course and Clinical Correlates of Retinal Diffusion Restrictions in Acute Central Retinal Artery Occlusion.

Authors:  L A Danyel; M Miszczuk; F Connolly; K Villringer; G Bohner; M Rossel-Zemkouo; E Siebert
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-15       Impact factor: 4.966

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.